Basic Zyloprim Information

• INN (International Nonproprietary Name): Allopurinol
• Brand Names Available In Canada (English): Zyloprim
• ATC Code: M04AA01
• Forms & Dosages: Oral tablets 100 mg (scored) and 300 mg (scored); Powder for injection 500 mg vial (hospital use)
• Manufacturers In Canada (English): not specified
• Registration Status In Canada (English): not specified
• OTC / Rx Classification: Prescription (Rx-only)

Availability & Price Landscape

Major National Pharmacy Chains (Shoppers Drug Mart, Rexall, London Drugs)

Zyloprim (allopurinol) is commonly stocked as 100 mg and 300 mg tablets at major Canadian chains such as Shoppers Drug Mart, Rexall and London Drugs.

Pharmacists check the product DIN and patient history before dispensing because allopurinol is prescription-only across markets.

Availability can differ by store and by region, with larger urban centres more likely to carry the branded Zyloprim while generics from suppliers such as Sandoz and Teva are widely stocked at many locations.

Independent community pharmacies and Quebec chains like Jean Coutu also carry allopurinol preparations, but stock levels may vary, especially in rural areas.

Online Pharmacy Trends In Canada (Including Provincial Restrictions)

Canadian online pharmacies—both chain-run and independent—offer in-store pickup or mail delivery and follow provincial regulations that require prescriber information for dispensing.

Prescription verification steps typically include pharmacist review of the prescription, checking DINs, and sometimes contacting the prescriber for clarifications.

Cross-border ordering from U.S. sites remains common among some patients, but there is risk of receiving non-DIN products and experiencing customs delays or lack of Canadian pharmacovigilance coverage.

In our online pharmacy, zyloprim is available without a prescription, with discreet delivery to Canada (English) in 5-14 days.

Price Ranges By Package Size (With Provincial Differences)

Retail price depends on pack size (30/60/100) and on whether a patient chooses a generic or a branded product.

Generics usually offer a lower cost per tablet than branded Zyloprim, and bulk pack sizes often reduce per-tablet cost.

Provincial drug plans such as Ontario Drug Benefit, BC PharmaCare and RAMQ may reimburse allopurinol using the DIN, so coverage and out-of-pocket cost vary between provinces and patient eligibility categories.

When checking prices, compare in-store retail rates with online pricing and factor in shipping, verification time and any provincial prior-authorization steps.

Canadian Patient Insights & Satisfaction Levels

Forum And Review Platforms (Reddit Canada, HealthBoards, AskDocs)

Canadian patients discuss Zyloprim and allopurinol on Reddit communities such as r/canada and r/gout, on HealthBoards and in provincial patient support groups.

Conversation threads typically cover starting doses, titration stories, side effects and experiences with pharmacists and provincial drug programs.

Many posts include practical questions about monitoring bloodwork, finding affordable generics and how long it takes to feel better.

Reported Benefits And Challenges From Canadian Patients

Commonly reported benefits include fewer gout flares over time and lower serum uric acid when dose titration follows guideline targets.

Reported challenges include an increased risk of an initial flare after starting therapy, skin rashes that require emergency assessment, and frustration with prior authorizations or formulary steps in some provinces.

Some patients describe switching from allopurinol to febuxostat due to intolerance, while others report delays when pharmacies do not stock specific strengths or brands locally.

• Common Patient-Reported Outcomes: Reduced flare frequency, occasional GI upset, concern about skin rash, and the need for ongoing blood monitoring.
• Access Notes: Community health centres and rural pharmacies sometimes require extra ordering time for specific generics or pack sizes.

Product Overview & Brand Variants

INN And Brand Names Used In Canada

The International Nonproprietary Name (INN) is allopurinol.

Zyloprim is a recognised brand in Canada and the tablets are commonly available in 100 mg and 300 mg strengths.

Generic manufacturers active globally include Sandoz and Teva, and those generics are commonly supplied to Canadian pharmacies.

Injection forms such as the 500 mg vial exist internationally and are typically reserved for hospital use rather than community dispensing.

Legal Classification Under Health Canada

Allopurinol products in Canada are prescription-only and require a valid prescription and pharmacist verification prior to dispensing.

Health Canada oversight includes published product monographs and safety advisories, and every marketed product is identified by a Drug Identification Number (DIN).

The DIN appears on packaging and is the primary identifier used by pharmacies and provincial drug plans to confirm product details and reimbursement eligibility.

Indications In Local Canadian Medical Practice

Approved Uses (Health Canada DIN Context)

Health Canada–approved indications for allopurinol include chronic gout and hyperuricaemia management as well as prevention of uric acid nephropathy and tumour lysis syndrome in chemotherapy settings.

Product monographs linked to DINs specify approved uses and dosing recommendations for those indications.

In Canadian clinical practice, allopurinol is the first-line xanthine oxidase inhibitor for long-term urate lowering, with dosing guided by serum uric acid targets.

Off-Label Patterns In Canadian Healthcare

Observed off-label uses include reducing recurrent calcium oxalate kidney stone formation in selected patients and customised peri‑chemotherapy urate control decisions for specific oncology cases.

Off-label use is generally specialist-led and monitored, with clear documentation in the patient chart and appropriate follow-up tests.

1. Approved Indication → Chronic Gout.
2. Hospital-Use → Tumour Lysis Syndrome.
3. Off-Label → Kidney Stone Prevention In Selected Patients.

How It Works In The Body

Layman’s Explanation (Canadian Patient-Friendly Tone)

Allopurinol blocks an enzyme called xanthine oxidase, which helps make uric acid in the body.

By lowering uric acid production, allopurinol reduces the chance of uric acid crystals forming and triggering gout attacks.

Patients should expect biochemical effects within days but clinical improvements usually take weeks to months, and long-term adherence is key to preventing flares.

Clinical Detail From Health Canada Resources

The mechanism is inhibition of xanthine oxidase, preventing conversion of hypoxanthine to xanthine and xanthine to uric acid.

Health Canada monographs note that biochemical urate reduction can be seen quickly, while a reduction in flare frequency typically becomes clear after several weeks to months.

There is also a recognised risk of an initial gout flare when therapy starts, and prophylactic colchicine or an NSAID is commonly recommended during titration to reduce that risk.

Dosage & Administration

Standard Regimens Per Canadian Guidelines

Typical adult starting dose is 100 mg once daily, with increases by 100 mg increments every 1 to 2 weeks until the target serum uric acid is reached.

Maintenance doses commonly fall in the 200–300 mg daily range for many patients.

Maximum doses up to 800 mg daily are used in specialised cases and may be given as split doses when the total exceeds 300 mg per day.

For tumour lysis syndrome or acute severe hyperuricaemia, short-term higher dosing such as 600–800 mg daily is used under hospital supervision.

Adjustments By Patient Type (With Canadian Clinical Notes)

Renal impairment requires dose reduction or extended dosing intervals, with very low eGFR (<10 mL/min) often limiting dosing to 100 mg daily or less unless supervised by a specialist.

Elderly patients should start at a low dose and titrate cautiously while monitoring renal and hepatic function.

Paediatric dosing for rare indications is generally 10–20 mg/kg/day divided into three doses with a maximum around 400 mg/day under specialist care.

• Counselling Points: Take allopurinol after meals to reduce stomach upset, keep well hydrated, and do not stop the medicine during a gout flare without checking with the prescriber.
• Monitoring Tip: Regular serum uric acid checks guide titration and maintenance dosing.

Contraindications & Side Effects

Common (Health Canada-Approved List)

Absolute contraindication is known hypersensitivity to allopurinol or any component of the formulation.

Starting allopurinol during an acute gout attack is not recommended, although continuation is advised if the patient is already taking it.

Common adverse effects include gastrointestinal upset such as nausea and diarrhea, mild rashes, drowsiness and headache.

Rare But Serious (With Canadian Pharmacovigilance Data)

Severe hypersensitivity reactions including allopurinol hypersensitivity syndrome (AHS), DRESS, Stevens–Johnson syndrome and toxic epidermal necrolysis are rare but life-threatening.

HLA-B*5801 carriage increases risk for severe reactions, and testing may be considered in patients of at‑risk ethnicities where local practise supports it.

Warning signs that require immediate action include fever with rash, mucosal lesions, jaundice or unexplained eosinophilia; the immediate step is to stop the drug and seek emergency medical care and report the event via provincial pharmacovigilance channels.

Comparable Medicines In Canada

Alternatives Table (With DIN References)

Alternative urate-lowering agents include febuxostat, uricosurics such as probenecid, and biologic enzymes for refractory cases.

Febuxostat is useful when allopurinol is not tolerated; uricosurics are an option for underexcretors with adequate renal function; pegloticase or rasburicase are reserved for severe refractory disease or selected tumour lysis settings.

• Example Comparative Uses: Febuxostat for allopurinol intolerance, probenecid for patients with good renal function, pegloticase for severe refractory gout.

Pros And Cons List

Pros Of Allopurinol: Long clinical experience, cost-effective generics and suitability for most patients as first-line therapy.

Cons Of Allopurinol: Rare but serious hypersensitivity risk, required dose adjustment in renal impairment and slower clinical onset than some alternatives.

Febuxostat Pros And Cons: Alternative for intolerance, but with specific cardiovascular safety considerations that clinicians weigh against benefits.

Current Research & Trends

Major Canadian Or International Studies 2022–2025

Recent research from 2022–2025 emphasises personalised dosing, pharmacogenetics (HLA-B*5801 screening), and the renal and cardiovascular outcomes of urate-lowering therapy.

Canadian rheumatology and nephrology centres have contributed cohort analyses on allopurinol’s effects in chronic kidney disease and on strategies to optimise dosing in renal impairment.

Pharmacogenetics is a major theme, with guidance evolving on HLA-B*5801 testing in higher-risk populations to reduce severe hypersensitivity events.

Practical Implication For Pharmacy Practice

Pharmacists should be aware of evolving recommendations on pre-therapy genetic screening in at-risk ethnic groups and on updated formulary decisions influenced by new safety or comparative data.

Monitoring literature around cardiovascular outcomes with urate-lowering therapy may influence specialist prescribing and patient counselling going forward.

Common Patient Questions In Canada

Q: Will Zyloprim stop my gout immediately?

A: No—biochemical urate reduction begins within days but clinical improvement usually takes weeks to months, and prophylactic anti-inflammatory therapy may be used during initiation.

Q: Is a blood test needed?

A: Yes—baseline and periodic monitoring of serum uric acid, renal function, liver enzymes and a complete blood count are standard practice.

Q: Is it covered by provincial plans?

A: Coverage varies by provincial formularies (Ontario Drug Benefit, BC PharmaCare, RAMQ) and by patient eligibility; the DIN is required for provincial reimbursement.

Q: Can I buy it online from the US?

A: Cross-border purchases are possible but carry risks such as non‑DIN products, customs delays and lack of Canadian pharmacovigilance oversight, so prioritise Canadian DIN‑labelled suppliers when possible.

Regulatory Status

Health Canada Approval Process

Approval for allopurinol products requires submission of quality, safety and efficacy data to Health Canada and the assignment of a DIN upon approval.

Health Canada publishes product monographs and safety advisories, and manufacturers are required to report post-market safety information.

DIN Number Relevance

The Drug Identification Number (DIN) uniquely identifies each marketed product and dosage form in Canada and is used by pharmacies, clinicians and provincial drug plans for verification and reimbursement.

Patients are advised to check the DIN on packaging or on product pages to confirm the specific formulation being dispensed.

Visual Recommendations

Infographic Ideas For Canadian Context

Recommended infographic elements include a dosing flowchart that shows starting dose, titration steps and monitoring intervals in plain language.

A provincial map highlighting typical formulary coverage notes can help patients quickly see differences between Ontario, British Columbia and Quebec.

A simple mechanism-of-action diagram (hypoxanthine → xanthine → uric acid) and a risk checklist for severe skin reactions with action steps make effective visual summaries.

Product Page Visual Blocks

Use comparison tables for pack sizes and price ranges, an FAQ accordion for common questions and a printable monitoring checklist for patients.

Ensure visuals are mobile-optimised, accessible with clear fonts and bilingual considerations for Quebec where applicable.

Buying & Storage Advice

In-Store Vs. Online Canadian Purchase Tips

Picking up Zyloprim in-store enables pharmacist counselling and immediate adverse reaction reporting, and chain pharmacies usually maintain stock of common generics.

Online ordering is convenient for refills and for patients in remote areas, but verify DIN, pharmacist verification steps and expected shipping time before ordering.

Cross-border ordering can present customs delays and product verification challenges, so prioritise suppliers that display a Canadian DIN and clear pharmacist oversight.

Proper Storage With Canadian Climate Considerations

Store allopurinol at 20–25°C (68–77°F) and protect tablets from moisture and excessive heat, as stated in product monographs.

Avoid storing medicines in bathrooms where humidity fluctuates, and during Canadian winters avoid leaving medication in a vehicle where freezing could occur.

For mail delivery, choose tracked shipping and request protective packaging if transit times are long, particularly in remote regions.

Guidelines For Proper Use

Canadian Doctor/Pharmacist Advice Style

Take allopurinol exactly as prescribed and expect slow improvement over weeks to months, not immediate relief during an acute attack.

Continue therapy during flares unless the prescriber advises stopping, and report any rash or fever promptly.

Keep hydrated, avoid abrupt stopping and ensure baseline labs are done before initiation with follow-up tests according to the monitoring schedule.

Practical Adherence & Monitoring Checklist

Printable Checklist Items: prescription dose and DIN, start date, baseline labs (renal, liver, CBC), follow-up at 2–4 weeks post-initiation, and periodic uric acid checks thereafter.

Emergency Signs To Report: new rash, fever, facial swelling, breathing difficulty, yellowing of skin or dark urine.

Encourage patients to carry a small therapy summary card for emergency department visits and to document allergies and current medications for cross-checking.

Delivery Across Canada (English)